Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: John F Beule who wrote (872)	1/14/1999 11:23:00 AM
From: jopawa	Read Replies (1) \| Respond to of 2539

Thursday January 14, 10:49 am Eastern Time Company Press Release SOURCE: Monsanto Company Monsanto and Micro Flo Announce Agreement On Glyphosate and Roundup Ready Crops ST. LOUIS, Jan. 14 /PRNewswire/ -- Monsanto Company (NYSE:MCT - news; NYSE: MTC - news) announced today a U.S. multi-year supply agreement with Micro Flo that also licenses rights to Monsanto's glyphosate herbicide registration data. The agreement will allow Micro Flo to register its own brand of glyphosate herbicide for sale in the United States. Additionally, terms of the license agreement allow Micro Flo to use its own brand of glyphosate herbicide over the top of Roundup Ready soybeans and Roundup Ready cotton beginning October 1, l999 and over Roundup Ready corn beginning October 1, 2000 in the United States. The agreement does not include lawn and garden uses. Monsanto's Roundup and Roundup Ultra herbicides, which include the active ingredient glyphosate, and Micro Flo's glyphosate brand(s) will compete with each other in the agricultural marketplace. All performance, crop safety and stewardship support concerning all uses of Micro Flo's brand(s), including over the top of pertinent Roundup Ready crops, is the responsibility of Micro Flo. The supply and licensing agreements apply to Micro Flo and its affiliates, including BASF Corporation. No additional details were provided and all other terms are confidential. As a life sciences company, Monsanto is committed to finding solutions to the growing global needs for food and health by sharing common forms of science and technology among agriculture, nutrition and health. The company's 30,000 employees worldwide make and market high-value agricultural products, pharmaceuticals and food ingredients. Micro Flo, a subsidiary of BASF Corporation, located in Lakeland, Fla., is engaged in the sale of high quality crop protection products. This press release contains certain forward-looking statements, including those related to the market for and sales of Roundup Ultra herbicide. These forward-looking statements are based on past experience and current expectations, but actual results may differ materially from those anticipated and there can be no guarantee that future results will be similar to those of the past. Certain factors which could cause actual results to differ materially from expected and historical results include: weather; price; new use; patent expiration; local farming practices; local economic conditions; the type of crops planted; and the availability, price and desirability of competitive products; as well as economic, competitive, governmental, intellectual property, technological and other factors identified in Monsanto Company's Form 10-K and Form 10-Q filings with the Securities and Exchange Commission. SOURCE: Monsanto Company

To: John F Beule who wrote (872)	1/14/1999 2:56:00 PM
From: Epicenter	Read Replies (1) \| Respond to of 2539

For what it's worth: As a scientist who is knowledgeable in this field, I don't particularly like this approach of therapeutics. Another concern I have is the track record of Cytel--it gets an "F" from me. I can't say it will never work but it's very much like "Geron-like" science. I was disappointed to find out that the Searle scientists is investing in this. The amount of money invested is not as important as the "quality" of scientific judgment that bothers me, IMHO. Epicenter